Skip to main content
. 2021 Sep 20;8:678614. doi: 10.3389/fcvm.2021.678614

Table 2.

Clinical indicator of patients with HFmrEF and HFpEF.

Biomarkers Ozlek et al. (6) Moliner et al. (15) Tromp et al. (17)
HFmrEF HFpEF HFmrEF HFpEF HFmrEF HFpEF
n = 246 n = 819 n = 134 n = 135 n = 128 n = 108
BUN H* L* NA NA L H
Creatinine H* L* NA NA NA NA
NT-proBNP H* L* H L H* L*
Uric acid H* L* NA NA NA NA
Ferritin H* L* NA NA NA NA
Neprilysin NA NA L H NA NA
Galectin-3 NA NA L H L H
sST2 NA NA L* H* L H
hs-TnT NA NA L H NA NA
sTfR NA NA L H NA NA
hs-CRP L H L H L* H*
Cystatin C NA NA L* H* NA NA

BUN, blood urea nitrogen; hs-CRP, high-sensitivity C-reactive protein; hs-TnT, high-sensitivity troponin T; NT-proBNP, N-terminal pro-B-type natriuretic peptide; sTfR, soluble transferrin receptor; sST2, soluble suppression of tumorigenesis-2; H, higher—P > 0.05; L, lower—P > 0.05; H*, higher—P < 0.05; L*, lower—P < 0.05.